According to Grifols's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.82946. At the end of 2023 the company had a P/S ratio of 1.11.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.11 | 4.19% |
2022 | 1.07 | -58.54% |
2021 | 2.58 | -8.41% |
2020 | 2.82 | -23.58% |
2019 | 3.69 | 21.44% |
2018 | 3.04 | -17.57% |
2017 | 3.68 | 30.3% |
2016 | 2.83 | -13.01% |
2015 | 3.25 | 9.59% |
2014 | 2.96 | -27.56% |
2013 | 4.09 | 35.61% |
2012 | 3.02 | 53.3% |
2011 | 1.97 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.92 | 372.32% | ๐บ๐ธ USA |
Amgen AMGN | 5.51 | 564.16% | ๐บ๐ธ USA |
Baxter BAX | 1.16 | 39.89% | ๐บ๐ธ USA |
Kimberly-Clark KMB | 2.32 | 179.69% | ๐บ๐ธ USA |